<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="chapter-article"><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><?noissn?><front><journal-meta><journal-id journal-id-type="publisher-id">978-3-319-99921-0</journal-id><journal-id journal-id-type="doi">10.1007/978-3-319-99921-0</journal-id><journal-id journal-id-type="nlm-ta">Prevention and Control of Infections in Hospitals</journal-id><journal-title-group><journal-title>Prevention and Control of Infections in Hospitals</journal-title><journal-subtitle>Practice and Theory</journal-subtitle></journal-title-group><isbn publication-format="print">978-3-319-99920-3</isbn><isbn publication-format="electronic">978-3-319-99921-0</isbn></journal-meta><article-meta><article-id pub-id-type="pmcid">7122166</article-id><article-id pub-id-type="publisher-id">80</article-id><article-id pub-id-type="doi">10.1007/978-3-319-99921-0_80</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Dangerous Microbes</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Andersen</surname><given-names>Bj&#x000f8;rg Marit</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.55325.34</institution-id><institution-id institution-id-type="ISNI">0000 0004 0389 8485</institution-id><institution>Department of Hospital Infections, </institution><institution>Oslo University Hospital, </institution></institution-wrap>Oslo, Norway </aff><aff id="Aff3"><label>3</label>Faculty of Health and Social Science, University of South-Eastern Norway, Oslo, Norway </aff></contrib-group><pub-date pub-type="epub"><day>25</day><month>9</month><year>2018</year></pub-date><fpage>1021</fpage><lpage>1028</lpage><permissions><copyright-statement>&#x000a9; Springer Nature Switzerland AG 2019</copyright-statement><license><license-p>This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">The most dangerous microbes for humans are those that are easily transmitted, virulent and invasive to central organs like the blood and lung, robust survivors in the environment, have a low infection dose and are without any specific treatment or vaccine. Most of them are zoonoses transmitted from animals and often with insects as vectors. The most dangerous microbes cause a very high mortality, are identified as high-risk agents or &#x0201c;biohazard-level 4&#x0201d; agents and are treated at the highest level of infection protection with strict isolation measures. Dangerous microbes occur as a problem mostly in countries with low hygiene standards/high population density and in tropical-subtropical areas. Infection control must always be based on hygienic measures and strict infection protection.</p><p id="Par2">This chapter is a short information about the most virulent and pathogenic agents, geographic area and severity of disease.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Microbes</kwd><kwd>Dangerous microbes</kwd><kwd>Geographic area of virulent agents</kwd><kwd>Dangerous virus and bacteria</kwd><kwd>Zoonosis</kwd><kwd>VHF</kwd><kwd>Anthrax</kwd><kwd>Plague</kwd><kwd>Biosafety level 4</kwd><kwd>Infection control</kwd><kwd>Survivors</kwd><kwd>High-risk microbes</kwd><kwd>Severity of disease</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Nature Switzerland AG 2019</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Dangerous Microbes</title><p id="Par3">New, emerging or re-emerging infectious diseases and agents still appear. More than 15 new potential human pathogenic microbe types may be registered every year. New infectious diseases and emerging virulence properties still appear, for example, avian influenza viruses (H5N1 and others), HTLV and other retroviruses, HPV, Sindbis virus, Parvovirus, Bocavirus, Coronavirus, or bacteria like <italic>Legionella</italic>, <italic>Borrelia</italic>, group A streptococci and meningococci [<xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR5">5</xref>].</p><p id="Par4">Virus not vaccine preventable or without specific treatment option, low infection dose and high capacity to survive in the environment will be a major problem if associated with incurable disease, disability or death. Virulent and dangerous microbes occur as a problem mostly in countries with low hygiene standards/high population density and in tropical-subtropical areas. Infection control must be based on hygienic measures and proper infection protection [<xref ref-type="bibr" rid="CR2">2</xref>&#x02013;<xref ref-type="bibr" rid="CR7">7</xref>].</p><p id="Par5">The most dangerous microbes for humans are those that are easily transmitted, virulent and invasive to the central organs like the blood and lung, robust survivors in the environment, have a low infection dose and are without any specific treatment or vaccine [<xref ref-type="bibr" rid="CR2">2</xref>&#x02013;<xref ref-type="bibr" rid="CR5">5</xref>]. Most of them are zoonosis transmitted from animals and often with insects as vectors [<xref ref-type="bibr" rid="CR8">8</xref>&#x02013;<xref ref-type="bibr" rid="CR12">12</xref>]. Dangerous microbes have also been used as biological weapons like anthrax, plague, botulism, <italic>Coxiella</italic>, <italic>Brucella</italic>, viral haemorrhagic fever (VHF) viruses, poxviruses and a number of other unusual agents [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR13">13</xref>&#x02013;<xref ref-type="bibr" rid="CR25">25</xref>]. In the United States, there was an anthrax bioterrorism attack in 2001 [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>].</p><p id="Par6">If the infectious agent and transmission ways are unknown and the situation is uncontrollable, it is important to follow pre-planned practical measures like strict isolation in negative air pressure isolation, registering of all contacts and the use of personal protective equipment (PPE) for air- and contact-borne infection [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR8">8</xref>&#x02013;<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR26">26</xref>&#x02013;<xref ref-type="bibr" rid="CR29">29</xref>].</p><sec id="Sec2"><title>Dangerous Virus</title><p id="Par7">During the last 20 years, there have been several large outbreaks of new and re-emerging viruses. Examples are systemic acute respiratory syndrome (SARS) (2002&#x02013;2003), avian influenza viruses (H5N1, 2005), pandemic influenza (2009), Middle East respiratory syndrome (MERS) (2012) and Ebola (2014 and 2016) [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>].</p><p id="Par8">VHF virus and a number of other special viruses are considered to cause the world&#x02019;s most dangerous infections with very high mortality, lack of therapeutic possibilities and often absence of effective vaccines. Such viruses are identified as high-risk agents or &#x0201c;biohazard-level 4&#x0201d; agents and are treated at the highest level of infection protection with strict isolation measures [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR26">26</xref>&#x02013;<xref ref-type="bibr" rid="CR28">28</xref>].<list list-type="bullet"><list-item><p id="Par9">Virus families, with members especially dangerous to humans, are <italic>Arenaviridae</italic>, <italic>Filoviridae</italic>, <italic>Flaviviridae</italic>, <italic>Bunyaviridae</italic>, <italic>Togaviridae</italic> and <italic>Paramyxoviridae</italic> (Nipah encephalitis virus, etc.) and several others. They are mostly vector borne by insects and animals (zoonosis), dependent on a tropical-subtropical climate and temperature. Therefore, the colder zones in Europe, America, Asia and Australia are nearly free from more such serious infectious agents (see the table below) [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>].</p></list-item><list-item><p id="Par10">Some very virulent viruses may be spread on all continents: TBE, RSSE, CCHF, rabies virus (<italic>Rhabdoviridae)</italic>, avian influenza virus (AH5N1) and other high-pathogenic influenza viruses (<italic>Orthomyxoviridae</italic>). SARS and MERS (<italic>Coronaviridae</italic>) may be spread globally as nosocomial infections. MERS is a newly discovered coronavirus-zoonosis (dromedaries, bats, etc.) and acts as SARS, also with a tendency for nosocomial spread in hospitals, still going on in the Middle East. [<xref ref-type="bibr" rid="CR30">30</xref>] These and other viruses are adapted to the climate and spread by direct transmission person-to-person, by increased mobility in the population and/or spread via new vectors, like animals, birds and insects [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR4">4</xref>].</p></list-item><list-item><p id="Par11">A few of these dangerous viruses are vaccine preventable, and specific antiviral therapy is lacking in most cases.</p></list-item></list></p><sec id="Sec3"><title>Other New Virulent Viruses</title><p id="Par12">
<list list-type="bullet"><list-item><p id="Par13"><italic>Zika</italic> virus&#x02014;newly discovered flavivirus in South America, with mild to serious symptoms and teratogenic effect [<xref ref-type="bibr" rid="CR11">11</xref>].</p></list-item><list-item><p id="Par14"><italic>Polio-like illnesses</italic>, especially among children, discovered in August 2014 in the United States. Probably caused by enterovirus D68 [<xref ref-type="bibr" rid="CR31">31</xref>].</p></list-item><list-item><p id="Par15"><italic>HIV aggressive variants</italic> (CRF19) have been detected in Cuba in 2015 and earlier in Africa, with a faster course from infection to AIDS development [<xref ref-type="bibr" rid="CR32">32</xref>].</p></list-item></list>
</p></sec></sec><sec id="Sec4"><title>Dangerous Bacteria</title><p id="Par16">Bacteria resistant to antibacterial drugs have developed rapidly among staphylococci (MRSA), enterococci (VRE), tuberculosis bacilli (multidrug-resistant mycobacteria) and gram-negative rods (ESBL) in the last 30&#x02013;50 years. From 2009 to 2010 onwards, super-resistant gram-negative rods (CRE, CPE) have increased rapidly with transmission of genes with total drug resistance (NDM-1) [<xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR5">5</xref>]. Bacteria sensitive to common antibacterial agents will probably not be a major problem in the future, unless changed antibacterial sensitivity.<list list-type="bullet"><list-item><p id="Par17">Anthrax is still endemic or hyperendemic on all continents in the world, mainly as a zoonosis among unvaccinated cattle [<xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. It has been known for more than 4000 years and was earlier called &#x0201c;Black bane&#x0201d;. Natural anthrax in human is associated with contact with sick animals and animal products. The bacterium <italic>Bacillus anthracis</italic> is producing lethal toxins and spores that can survive in the environments for 100 years or more. Minimum infectious dose is 1&#x02013;3 spores, and toxin-producing anthrax may cause skin, lung or intestinal anthrax, dependent on the transmission via contact, air or food. The non-skin anthrax has a very high lethality. Today, about 2000 people are infected each year, from eating or handling infected meat. During peace time, there are few incidents of threats using bioterror weapons like anthrax. However, autumn 2001 anthrax was spread in the United States by &#x0201c;powder letters&#x0201d; [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>].</p></list-item><list-item><p id="Par18">Plague, caused by <italic>Yersinia pestis</italic> (<italic>Enterobacteriaceae</italic>), is a zoonotic disease, vector-transmitted from infected rodents to humans via infected insects (fleas and lice) [<xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. It is one of the great historical diseases. In the last 1500 years, plague has killed more than 200 million people during large epidemics (Black Death), especially from the year 1347. Still, plague causes bubonic-glandular pest, lung pest and/or septicaemia in 2000&#x02013;3000 cases each year, and more than 10 outbreaks (Africa, Asia, Australia, Madagascar) have occurred since the year 2000 [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR34">34</xref>].</p></list-item><list-item><p id="Par19">Cholera caused by <italic>Vibrio cholera</italic> is one of the great quarantine diseases, called &#x0201c;mother of all epidemics&#x0201d;, still very active in Asia and Africa. Cholera is associated with contaminated water, war and nature catastrophes, like in Haiti 2010, with 670,000 cholera cases (profuse diarrhoea) [<xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR35">35</xref>].</p></list-item><list-item><p id="Par20"><italic>Brucella</italic> species (<italic>Brucellaceae</italic>) are one of the most important zoonotic diseases both for animals and humans all over the world. They easily spread via contact and air from animals and food, survive in the environment for months especially during colder seasons, are very easily transmitted and may cause nosocomial infections, chronic febris undulans, septicaemia and lung diseases. Vaccination of animals may eradicate the zoonotic disease [<xref ref-type="bibr" rid="CR15">15</xref>]. <italic>Brucella</italic> are particularly related to laboratory outbreaks but are easily transferable outside the laboratory and are considered highly infectious [<xref ref-type="bibr" rid="CR36">36</xref>].</p></list-item><list-item><p id="Par21"><italic>Francisella tularensis</italic> (zoonosis) is defined as a category A bioterrorism agent, highly infectious and increasing in the society, has low infection dose (one to ten bacteria) and can be inhaled or infected via food and water [<xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. Occasionally, such patients are detected in hospitals, even in the operating department [<xref ref-type="bibr" rid="CR37">37</xref>]. Tularemia is a zoonotic disease or colonization among wild animals as rodents and hares and may survive at colder seasons for long periods in water, amoebas, birds and insects like ticks. The infection (skin, lung, intestine) is transmitted via contact with infected animals, inhalation of airborne bacteria, contaminated water and ticks.</p></list-item><list-item><p id="Par22"><italic>Botulism</italic> is caused by a bacterial-produced toxin (<italic>Clostridium botulinum</italic>) that causes paresis and is common in soil as spores [<xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR5">5</xref>]. The disease can be associated with toxin formation in contaminated and poorly canned foods, shrimp fish, bacon, etc. under anaerobic conditions and randomly affects both healthy people and vulnerable groups, such as infants who have had honey infected with the bacterium, which has happened repeatedly [<xref ref-type="bibr" rid="CR38">38</xref>]. The toxin is the most dangerous we know and is on the list of bioterrorism.</p></list-item><list-item><p id="Par23">Family <italic>Rickettsiaceae</italic> is associated with many different types of small, intracellular microbes that are zoonotic and survive for a long time in the nature and in infected animals, birds, insects, water and amoeba [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. <italic>Coxiella burnetii</italic> is a global zoonosis among animals like sheep and goats and may be airborne for several kilometres, causing frequent outbreaks of Q-fever in Europe in more than 4000 cases in the Netherlands during 2007&#x02013;2010 [<xref ref-type="bibr" rid="CR10">10</xref>]. <italic>Rickettsia</italic> species are more than 25 types, and many of them, especially the typhus group, are causing severe diseases. Humans are mostly infected by insects, including ticks from infected wild animals and rodents usually found in tropical or subtropical areas, but climatic changes, lack of good hygiene, war and natural catastrophes may spread these infections. During the period 1881&#x02013;1920, 30 million people got epidemic typhus, and three million died in East Europe and Russia [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR10">10</xref>].</p></list-item></list></p></sec><sec id="Sec5"><title>Other Bacteria That Are Causing Concern</title><p id="Par24">
<list list-type="bullet"><list-item><p id="Par25"><italic>Borrelia</italic> (<italic>Spirochetaceae</italic>) has an increasing number of species that may infect human cases all over the world. The disease may cause chronic infections in the skin, muscles, heart, nerve tissue and brain. Borreliosis is a typical emerging zoonosis, spread via different ticks from animals and birds over large geographic areas and with large climatic variations [<xref ref-type="bibr" rid="CR9">9</xref>].</p></list-item><list-item><p id="Par26"><italic>Syphilis</italic> (<italic>Spirochetaceae</italic>) and <italic>Treponema pallidum</italic> are old, historical diseases, transmitted via sex, from mother to child during pregnancy and via blood products. Now re-emerging and increasing worldwide [<xref ref-type="bibr" rid="CR9">9</xref>].</p></list-item><list-item><p id="Par27">Other spirochetes or the like may cause zoonosis, like <italic>Borrelia recurrentis</italic> and <italic>Leptospirosis</italic> [<xref ref-type="bibr" rid="CR9">9</xref>].</p></list-item><list-item><p id="Par28"><italic>Burkholderia pseudomallei</italic> is causing melioidosis, pneumonia, septicaemia, disseminated infection and shock. Incubation period may be up to 20&#x02013;40 years. It is a long survivor in the environment (2&#x02013;10 years), robust at tropical-subtropical temperatures &#x0003e;25&#x000a0;&#x000b0;C and is very dangerous. Endemic in Southeast Asia and may be spread by increasing globalization [<xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR5">5</xref>].</p></list-item></list>
</p></sec><sec id="Sec6"><title>Other Infective/Dangerous Agents</title><p id="Par29">
<list list-type="bullet"><list-item><p id="Par30"><italic>Fungi and mould</italic>&#x02014;different types are especially related to floods, water damage, etc. and to contamination of medical products and equipment [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. Especially, the newly defined <italic>Candida auris</italic> may be very virulent.</p></list-item><list-item><p id="Par31"><italic>Prion disease-new Shy-Drager syndrome</italic> is rediscovered in 2015; Multiple-system atrophy (MSA) [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR41">41</xref>].</p></list-item><list-item><p id="Par32"><italic>Ricin</italic> is a plant-derived toxin that is still used for bioterrorism in letters to, among others, President Obama [<xref ref-type="bibr" rid="CR42">42</xref>].</p></list-item></list>
<table-wrap id="Taba"><caption><p>Serious and unusual microbial infections</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Microbes</th><th>Geographic area</th><th>Disease</th></tr></thead><tbody><tr><td colspan="3">Virus</td></tr><tr><td colspan="3">
<italic>Arena virus</italic>
</td></tr><tr><td>Lassa</td><td>West Africa</td><td>Severe, often fatal</td></tr><tr><td>Guanarito</td><td>Venezuela</td><td>Severe</td></tr><tr><td>Junin (Argentine haemorrhagic fever-HF)</td><td>Argentina</td><td>Severe</td></tr><tr><td>Machupo (Bolivian haemorrhagic fever)</td><td>Bolivia</td><td>Severe</td></tr><tr><td>Sabia</td><td>Brazil</td><td>Severe</td></tr><tr><td>LCM</td><td>Global</td><td>Mild to severe</td></tr><tr><td colspan="3">
<italic>Filovirus</italic>
</td></tr><tr><td>Marburg</td><td>Africa</td><td>23&#x02013;100 % fatal</td></tr><tr><td>Ebola</td><td>Africa</td><td>20&#x02013;100 % fatal</td></tr><tr><td colspan="3">
<italic>Bunyaviridae (over 60 viral types from asymptomatic to fatal)</italic>
</td></tr><tr><td>Rift Valley fever</td><td>Africa</td><td>1 % develops HF</td></tr><tr><td>California enceph</td><td>United States, Europe</td><td>2 % fatal</td></tr><tr><td>Crimean-Congo haemorrhagic fever (CCHF)</td><td>Africa, Asia, Europe</td><td>Severe</td></tr><tr><td>Hantaan group</td><td>North and South America, Europe, Asia</td><td>Moderate to severe</td></tr><tr><td colspan="3">
<italic>Arbovirus (Togaviridae and Flaviviridae)</italic>
</td></tr><tr><td>Tick&#x0200b;-borne (TBE) encephalitis virus complex</td><td>All continents</td><td>Moderate to fatal</td></tr><tr><td>Russian spring and summer encephalitis (RSSE)</td><td/><td/></tr><tr><td>Omsk haemorrhagic fever</td><td/><td/></tr><tr><td>Central European encephalitis viruses</td><td/><td/></tr><tr><td>Venezuelan equine encephalitis virus</td><td/><td>Moderate to severe</td></tr><tr><td>Yellow fever virus</td><td>Africa, America</td><td>Moderate to severe</td></tr><tr><td>Semliki Forest virus</td><td>Africa, epidemic</td><td>Mild to fatal</td></tr><tr><td>Dengue virus</td><td>All tropical-subtropical areas</td><td>Mild to fatal</td></tr><tr><td>Japanese B encephalitis</td><td>Asia; Korea, Japan, Philippines</td><td>Often fatal</td></tr><tr><td>
<italic>Rabies</italic>
</td><td>In all parts of the world</td><td>100% fatal without tr.</td></tr><tr><td>
<italic>Monkey pox (B)</italic>
</td><td>Animal experiments</td><td>Severe, often fatal</td></tr><tr><td>
<italic>Smallpox Virus</italic>
</td><td>Eradicate, but kept</td><td>Severe, often fatal in unvaccinated</td></tr><tr><td>
<italic>Avian influenza A H5N1</italic>
</td><td>Asia, Africa, Europe</td><td>80% fatal without treat</td></tr><tr><td>
<italic>Nipah encephalitis virus (paramyxovirus)</italic>
</td><td>Asia, Malaysia, India, Bangladesh</td><td>75% fatal</td></tr><tr><td colspan="3">
<italic>Corona Virus</italic>
</td></tr><tr><td>&#x02003;Systemic acute respiratory syndrome (SARS)</td><td>Asia, Canada, proliferation</td><td>Severe, 10% fatal</td></tr><tr><td>&#x02003;Middle East respiratory syndrome (MERS)</td><td>Middle East, emerging</td><td>Severe, 30&#x02013;40% fatal</td></tr><tr><td colspan="3">Bacteria</td></tr><tr><td colspan="3">
<italic>Richettsiaceae</italic>
</td></tr><tr><td>&#x02003;<italic>Rickettsia</italic></td><td>All continents</td><td>Many types, severe</td></tr><tr><td>&#x02003;<italic>Orientia</italic></td><td>Asia, Australia</td><td>Moderate to severe</td></tr><tr><td>&#x02003;<italic>Bartonellaceae</italic></td><td>All continents</td><td>Moderate to severe</td></tr><tr><td>&#x02003;<italic>Coxiella burnetii</italic></td><td>All continents</td><td>Moderate to severe</td></tr><tr><td>
<italic>Bacillus anthracis</italic>
</td><td>All continents</td><td>Moderate to severe</td></tr><tr><td>
<italic>Brucella</italic>
</td><td>All continents</td><td>Mild to severe</td></tr><tr><td>
<italic>Burkholderia pseudomallei</italic>
</td><td>Asia</td><td>Mild to severe</td></tr><tr><td>
<italic>Francisella tularensis</italic>
</td><td>All continents</td><td>Mild to severe</td></tr><tr><td>
<italic>Vibrio cholera</italic>
</td><td>Asia, Africa and South America</td><td>Mild to severe</td></tr><tr><td>
<italic>Bacillus anthracis</italic>
</td><td>All continents</td><td>Moderate to severe</td></tr><tr><td>
<italic>Yersinia pestis</italic>
</td><td>Africa and Asia</td><td>Moderate to severe</td></tr></tbody></table></table-wrap>
</p></sec></sec></body><back><fn-group><fn><p>
<italic>Current agents are described in more detail in: Andersen BM. Part 1. Microbiology and infection protection. Fagbokforlaget 2014.</italic>
</p></fn></fn-group><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Mandell</surname><given-names>D</given-names></name></person-group><source>Bennet&#x02019;s principles and practice of infectious diseases</source><year>2015</year><edition>8</edition><publisher-loc>Philadelphia</publisher-loc><publisher-name>Churchill Livingston</publisher-name></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>BM</given-names></name></person-group><source>Pathogenic bacteria-diagnostic, treatment and infection control</source><year>2000</year><publisher-loc>Oslo</publisher-loc><publisher-name>Gyldendal Akademisk</publisher-name></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>BM</given-names></name></person-group><source>Bacteria and disease</source><year>2005</year><publisher-loc>Oslo</publisher-loc><publisher-name>Gyldendal Academisk</publisher-name></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>BM</given-names></name><name><surname>Lereim</surname><given-names>I</given-names></name><name><surname>Hochlin</surname><given-names>K</given-names></name></person-group><article-title>Serious, unusual dangerous infections</article-title><source>Handbook in hygiene and infection control for hospitals</source><year>2008</year><publisher-loc>Oslo</publisher-loc><publisher-name>Ullev&#x000e5;l University Hospital</publisher-name><fpage>550</fpage><lpage>591</lpage></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>BM</given-names></name></person-group><source>Handbook in hygiene and infection control for hospitals. Part 1. Microbiology and infection control</source><year>2014</year><publisher-loc>Norway</publisher-loc><publisher-name>Fagbokforlaget</publisher-name></element-citation></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="other">European Parliament and Council Directive 2000/54/EC of 18 September 2000 on the protection of workers from the risks related to exposure to biological agents at work.</mixed-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="other">Ministry of Labour and Administration. Regulations on protection against exposure to biological factors (bacteria, viruses, fungi and more) in the workplace. FOR OSLO: 1997-12-19 nr.1322.</mixed-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>BM</given-names></name></person-group><article-title>Zoonosis-transmitted from animals, insects and environment</article-title><source>Handbook in hygiene and infection control for hospitals. Part 1</source><year>2014</year><publisher-loc>Norway</publisher-loc><publisher-name>Fagbokforlaget</publisher-name><fpage>144</fpage><lpage>153</lpage></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>BM</given-names></name></person-group><article-title>Borreliosis and other spirochetes-zoonosis</article-title><source>Handbook in hygiene and infection control for hospitals. Part 1</source><year>2014</year><publisher-loc>Norway</publisher-loc><publisher-name>Fagbokforlaget</publisher-name><fpage>154</fpage><lpage>162</lpage></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>BM</given-names></name></person-group><article-title>Coxiella, rickettsia and other small bacteria&#x000a0;&#x02013; often intracellular&#x000a0;&#x02013; zoonosis</article-title><source>Handbook in hygiene and infection control for hospitals. Part 1</source><year>2014</year><publisher-loc>Norway</publisher-loc><publisher-name>Fagbokforlaget</publisher-name><fpage>163</fpage><lpage>166</lpage></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>BM</given-names></name></person-group><article-title>Other serious viral infections - zoonosis</article-title><source>Handbook in hygiene and infection control for hospitals. Part 1</source><year>2014</year><publisher-loc>Norway</publisher-loc><publisher-name>Fagbokforlaget</publisher-name><fpage>278</fpage><lpage>290</lpage></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>BM</given-names></name></person-group><article-title>Ebola, Lassa, and other haemorrhagic viruses</article-title><source>Handbook in hygiene and infection control for hospitals. Part 1</source><year>2014</year><publisher-loc>Norway</publisher-loc><publisher-name>Fagbokforlaget</publisher-name><fpage>291</fpage><lpage>299</lpage></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>BM</given-names></name></person-group><article-title>Anthrax and emergency routines at Ullev&#x000e5;l University Hospital</article-title><source>Tidsskr Nor Legeforen</source><year>2002</year><volume>122</volume><fpage>852</fpage><lpage>855</lpage></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borio</surname><given-names>L</given-names></name><name><surname>Inglesby</surname><given-names>BL</given-names></name><name><surname>Peters</surname><given-names>CJ</given-names></name><etal/></person-group><article-title>Haemorrhagic fever viruses as biological weapons: medical and public health management</article-title><source>JAMA</source><year>2002</year><volume>287</volume><fpage>2391</fpage><lpage>2405</lpage><pub-id pub-id-type="doi">10.1001/jama.287.18.2391</pub-id><pub-id pub-id-type="pmid">11988060</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jernigan</surname><given-names>JA</given-names></name><name><surname>Stephens</surname><given-names>DS</given-names></name><name><surname>Ashford</surname><given-names>DA</given-names></name><name><surname>Omenaca</surname><given-names>C</given-names></name><name><surname>Topiel</surname><given-names>MS</given-names></name><name><surname>Galbraith</surname><given-names>M</given-names></name><etal/></person-group><article-title>Bioterrorism-related inhalation anthrax: the first 10 cases reported in the United States</article-title><source>Emerg Infect Dis</source><year>2001</year><volume>7</volume><fpage>933</fpage><lpage>944</lpage><pub-id pub-id-type="doi">10.3201/eid0706.010604</pub-id><pub-id pub-id-type="pmid">11747719</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inglesby</surname><given-names>TV</given-names></name><name><surname>O&#x02019;Toole</surname><given-names>T</given-names></name><name><surname>Hendersen</surname><given-names>DA</given-names></name><etal/></person-group><article-title>Anthrax as a biological weapon, 2002: updated recommendations for management</article-title><source>JAMA</source><year>2002</year><volume>287</volume><fpage>2236</fpage><lpage>2252</lpage><pub-id pub-id-type="doi">10.1001/jama.287.17.2236</pub-id><pub-id pub-id-type="pmid">11980524</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yakupogullari</surname><given-names>Y</given-names></name><name><surname>Koroglu</surname><given-names>M</given-names></name></person-group><article-title>Nosocomial spread of <italic>Bacillus anthracis</italic></article-title><source>J Hosp Infect</source><year>2007</year><volume>66</volume><fpage>401</fpage><lpage>440</lpage><pub-id pub-id-type="doi">10.1016/j.jhin.2007.05.002</pub-id><pub-id pub-id-type="pmid">17602791</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dull</surname><given-names>PM</given-names></name><name><surname>Wilson</surname><given-names>KE</given-names></name><name><surname>Kournikakis</surname><given-names>B</given-names></name><name><surname>Whitney</surname><given-names>EAS</given-names></name><name><surname>Boulet</surname><given-names>CA</given-names></name><name><surname>Ho</surname><given-names>JYW</given-names></name><etal/></person-group><article-title><italic>Bacillus anthracis</italic> aerosolization associated with a contaminated mail sorting machine</article-title><source>Emerg Infect Dis</source><year>2002</year><volume>8</volume><fpage>1044</fpage><lpage>1047</lpage><pub-id pub-id-type="doi">10.3201/eid0810.020356</pub-id><pub-id pub-id-type="pmid">12396913</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weis</surname><given-names>CP</given-names></name><name><surname>Intrepido</surname><given-names>AJ</given-names></name><name><surname>Miller</surname><given-names>AK</given-names></name><name><surname>Cowin</surname><given-names>PG</given-names></name><name><surname>Durno</surname><given-names>MA</given-names></name><name><surname>Gebhart</surname><given-names>JS</given-names></name><etal/></person-group><article-title>Secondary aerosolization of viable <italic>Bacillus anthracis</italic> spores in a contaminated US Senate office</article-title><source>J Am Med Ass</source><year>2002</year><volume>288</volume><fpage>2853</fpage><lpage>2858</lpage><pub-id pub-id-type="doi">10.1001/jama.288.22.2853</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>CJ</given-names></name><name><surname>Hartley</surname><given-names>DM</given-names></name></person-group><article-title>Anthrax inhalation and lethal human infection</article-title><source>Lancet</source><year>2002</year><volume>359</volume><fpage>710</fpage><lpage>711</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(02)07792-9</pub-id><pub-id pub-id-type="pmid">11879895</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Byrne</surname><given-names>D</given-names></name></person-group><article-title>Bioterrorism: crime and opportunity</article-title><source>Eurosurveillance</source><year>2001</year><volume>6</volume><fpage>157</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.2807/esm.06.11.00382-en</pub-id><pub-id pub-id-type="pmid">11891385</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coignard</surname><given-names>B</given-names></name></person-group><article-title>Bioterrorism preparedness and response in European public health institutes</article-title><source>Eurosurveillance</source><year>2001</year><volume>6</volume><fpage>159</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.2807/esm.06.11.00383-en</pub-id><pub-id pub-id-type="pmid">11891386</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levy-Bruhl</surname><given-names>D</given-names></name><name><surname>Guerin</surname><given-names>N</given-names></name></person-group><article-title>The use of smallpox virus as a biological weapon: the vaccination situation in France</article-title><source>Eurosurveillance</source><year>2001</year><volume>6</volume><fpage>171</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.2807/esm.06.11.00385-en</pub-id><pub-id pub-id-type="pmid">11891388</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Rebman</surname><given-names>T</given-names></name></person-group><article-title>Infectious disease disaster: bioterrorism, emerging infections, and pandemics</article-title><source>APIC text of infection control and epidemiology</source><year>2014</year><publisher-loc>St. Louis</publisher-loc><publisher-name>APIC, St. Louis University</publisher-name><fpage>1201</fpage><lpage>1222</lpage></element-citation></ref><ref id="CR25"><label>25.</label><mixed-citation publication-type="other">English JF, Cundiff MY, Malone JD et al. Bioterrorism readiness plan: a template for healthcare facilities. APIC, CDC; 13 April 1999.</mixed-citation></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="other">Promed mail September 14, 2014. Andersen BM. Infection control is not working.</mixed-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="other">Andersen BM. International infection control guidelines for Ebola. Hospital Healthcare Europe. Facilities management; April 2015. <ext-link ext-link-type="uri" xlink:href="http://www.hospitalhealthcare.com">www.hospitalhealthcare.com</ext-link>.</mixed-citation></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="other">CDC. Guidance on personal protective equipment to be used by Healthcare Workers during management of patients with Ebola virus disease in US hospitals, including procedures for putting on (donning) and removal, 20 October 2014.</mixed-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKay</surname><given-names>I</given-names></name><name><surname>Sax</surname><given-names>H</given-names></name><name><surname>Harbarth</surname><given-names>S</given-names></name><name><surname>Bernard</surname><given-names>L</given-names></name><name><surname>Pittet</surname><given-names>D</given-names></name></person-group><article-title>Multi-resistant infections in repatriated patients after natural disaster: lessons learned from the 2004 tsunami for hospital infection control</article-title><source>J Hosp Infect</source><year>2008</year><volume>68</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.jhin.2007.10.018</pub-id><pub-id pub-id-type="pmid">18079019</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><mixed-citation publication-type="other">Promed-mail August 28, 2015. MERS-COV: Jordan, Saudi Arabia, Nosocomial.</mixed-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pastula</surname><given-names>DM</given-names></name><name><surname>Aliabadi</surname><given-names>N</given-names></name><name><surname>Haynes</surname><given-names>AK</given-names></name><etal/></person-group><article-title>Acute neurological disease of unknown etiology in children - Colorado, August-September 2014</article-title><source>MMWR</source><year>2014</year><volume>63</volume><fpage>1</fpage><lpage>2</lpage></element-citation></ref><ref id="CR32"><label>32.</label><mixed-citation publication-type="other">Promed-mail February 14, 2015. HIV-Cuba: New aggressive variant, CRF19.</mixed-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>BM</given-names></name></person-group><source>Anthrax. Bacteria and disease. Epidemiology, infections and infection protection</source><year>2005</year><publisher-loc>Oslo</publisher-loc><publisher-name>Gyldendal Akademisk</publisher-name><fpage>9</fpage><lpage>44</lpage></element-citation></ref><ref id="CR34"><label>34.</label><mixed-citation publication-type="other">Promed mail November 21, 2014. Plague - Madagascar.</mixed-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>BM</given-names></name></person-group><article-title>Cholera (<italic>Vibrio cholerae</italic>)</article-title><source>Handbook in hygiene and infection control for hospitals. Part 1</source><year>2014</year><publisher-loc>Norway</publisher-loc><publisher-name>Fagbokforlaget</publisher-name><fpage>105</fpage><lpage>107</lpage></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lowe</surname><given-names>CF</given-names></name><name><surname>Showler</surname><given-names>AJ</given-names></name><name><surname>Perera</surname><given-names>S</given-names></name><etal/></person-group><article-title>Hospital-associated transmission of <italic>Brucella melitensis</italic> outside the laboratory</article-title><source>Emerg Infect Dis</source><year>2015</year><volume>21</volume><fpage>150</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.3201/eid2101.141247</pub-id><pub-id pub-id-type="pmid">25531198</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becker</surname><given-names>SL</given-names></name><name><surname>Splettesteesser</surname><given-names>WD</given-names></name><name><surname>Kim</surname><given-names>YJ</given-names></name><etal/></person-group><article-title>Potential risk of aerosol-borne <italic>Francisella tularensis</italic> transmission in the operating room</article-title><source>Infect Control Hosp Epidemiol</source><year>2015</year><volume>36</volume><fpage>490</fpage><lpage>491</lpage><pub-id pub-id-type="doi">10.1017/ice.2015.4</pub-id><pub-id pub-id-type="pmid">25782911</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valley</surname><given-names>ML</given-names></name><name><surname>Bye</surname><given-names>K</given-names></name><name><surname>Nilsen</surname><given-names>KB</given-names></name><name><surname>R&#x000f8;rvik</surname><given-names>LM</given-names></name><name><surname>Tessem</surname><given-names>GAG</given-names></name></person-group><article-title>An infant with acute paresis</article-title><source>Tidsskr Nor Legeforen</source><year>2015</year><volume>135</volume><fpage>1455</fpage><lpage>1458</lpage><pub-id pub-id-type="doi">10.4045/tidsskr.14.1419</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><mixed-citation publication-type="other">CDC. Brandt M, Brown C, Burkhart J, et al. Mould-preventing strategies and possible health effects in the aftermath of hurricanes and major floods. MMWR. 2006;55:1&#x02013;27.</mixed-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>BM</given-names></name></person-group><article-title>Fungi-human pathogenic</article-title><source>Handbook in hygiene and infection control for hospitals. Part 1</source><year>2014</year><publisher-loc>Norway</publisher-loc><publisher-name>Fagbokforlaget</publisher-name><fpage>393</fpage><lpage>399</lpage></element-citation></ref><ref id="CR41"><label>41.</label><mixed-citation publication-type="other">Promed-mail September 17, 2015. Prion disease updated: novel prion disease - SHY-DRAGER syndrome.</mixed-citation></ref><ref id="CR42"><label>42.</label><mixed-citation publication-type="other">Promed-mail April 17, 2013. Ricin-USA: Washington, DC, Letters.</mixed-citation></ref></ref-list></back></article>